RedHill Biopharma Ltd. (RDHL) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 | Q3'20 |
|---|
| Cash from Operations | -2.51M | -2.51M | -1.59M | -1.59M | -3.09M | -3.09M | -9.02M | -9.02M | -10.59M | -7.19M | -2.42M | -6.03M | -16.58M | -4.16M | -14.86M | -19.02M | -18.9M | -12.27M | -12.71M | -9.17M |
| Operating CF Margin % | -122.95% | -122.95% | -58.2% | -58.2% | -240.47% | -240.47% | -1589.87% | -1589.87% | -589.59% | -199.67% | -18.92% | -34.34% | -90.38% | -31.71% | -67.32% | -88.04% | -87.89% | -59.62% | -59.2% | -43.79% |
| Operating CF Growth % | 18.92% | 18.92% | 82.36% | 82.36% | 70.8% | 56.96% | -272.68% | -49.68% | 36.14% | -72.95% | 83.71% | 68.32% | 12.26% | 66.13% | -16.95% | -107.45% | -25.74% | -15.47% | 8.39% | -3.11% |
| Net Income | -2.07M | -2.07M | -2.59M | -2.59M | -1.54M | -1.54M | -13.54M | -13.54M | 761K | 50.24M | -3.73M | -35.7M | -11.71M | -17.14M | -24.37M | -21.39M | -29.12M | -22.86M | -24.33M | -18.64M |
| Depreciation & Amortization | 84K | 84K | 100.5K | 100.5K | 209K | 209K | 202.5K | 202.5K | -58.9M | 60.48M | 2.01M | 2.09M | 1.92M | 2.14M | 11.19M | 2.34M | 2.29M | 2.32M | 2.55M | 2.58M |
| Stock-Based Compensation | 148.5K | 148.5K | 218K | 218K | 114.5K | 114.5K | 399K | 399K | 705K | 144K | 1.14M | 1.61M | 618K | 2.31M | 1.88M | 2.19M | 5.27M | 872K | 1.08M | 1.7M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4K | 37K | 17K | 17K | 52K | 287K | 36K |
| Other Non-Cash Items | -529K | -529K | 228K | 228K | -3.5M | -3.5M | 7.63M | 7.63M | 46.21M | -120.81M | -6.08M | 25.63M | -2.02M | 3.12M | 678K | 886K | 1.23M | 2.69M | 2.66M | 2.08M |
| Working Capital Changes | -144.5K | -144.5K | 451.5K | 451.5K | 1.63M | 1.63M | -3.71M | -3.71M | 638K | 2.76M | 4.24M | 342K | -5.38M | 5.41M | -4.23M | -3.06M | 1.42M | 4.71M | 5.33M | 3.12M |
| Change in Receivables | -1.41M | -1.41M | -782.5K | -782.5K | 808.5K | 808.5K | 156K | 156K | 3.95M | 27.67M | 1.49M | -2.25M | -7.82M | 5.74M | -1.64M | 62K | -6.79M | 5.35M | -16.23M | 6.15M |
| Change in Inventory | 241K | 241K | 76.5K | 76.5K | 292.5K | 292.5K | 275K | 275K | -3.31M | 5.15M | 1.57M | -865K | 2.55M | 538K | -1.7M | -4.35M | 507K | -2.74M | -1.43M | -350K |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.25M | 136K | -554K | 411K | -1.33M | -5.96M | -3.58M | 1.94M | 6.77M | -5.02M | 4.98M | 1.26M |
| Cash from Investing | -2K | -2K | -4K | -4K | -500 | -500 | 5.5K | 5.5K | -7K | 0 | -8.5M | -22K | -163K | 8.49M | 3.5M | -8.52M | -3.5M | 387K | 7.85M | 1.17M |
| Capital Expenditures | -2K | -2K | -4K | -4K | -500 | -500 | -2K | -2K | -7K | 0 | -1.33K | -22K | -163K | -13K | -3K | -21K | -3K | -88K | -49K | -901K |
| CapEx % of Revenue | 0.1% | 0.1% | 0.15% | 0.15% | 0.04% | 0.04% | 0.35% | 0.35% | 0.39% | - | 0.01% | 0.13% | 0.89% | 0.1% | 0.01% | 0.1% | 0.01% | 0.43% | 0.23% | 4.3% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 7.5K | 7.5K | 0 | 0 | 1.33K | 55.67K | 53.4K | 8.5M | 3.5M | -8.5M | -3.5M | 475K | 7.9M | -735K |
| Cash from Financing | 1.63M | 1.63M | 258.5K | 258.5K | 3.95M | 3.95M | 8.31M | 8.31M | 3K | 4.81M | 7.2M | -5.72M | 14.92M | -4.94M | 17.57M | -999K | -1.77M | 58.66M | 7.94M | 11.96M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -293K | -296K | -384K | -621K | -355K | -115K | -454K | -442K | -402K | -383K | -424K | -784K |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.61M | 6.71M | 7.58M | -106.25K | 15.51M | 713K | 19.82M | 499K | 273K | 57.94M | 8.37M | 9.14M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.63M | 1.63M | 258.5K | 258.5K | 3.95M | 3.95M | 8.31M | 8.31M | 1.91M | -1.6M | 0 | -4.99M | -236K | -5.54M | -1.8M | -1.06M | -1.64M | 1.1M | -1K | 3.6M |
| Net Change in Cash | 0 | 0 | 0 | -7.28M | 7.28M | 0 | 0 | -7M | -10.57M | -2.4M | 4.76M | -11.78M | -1.86M | -627K | 6.22M | -28.56M | -24.16M | 46.68M | 3.1M | 3.93M |
| Free Cash Flow | -2.51M | -2.51M | -1.6M | -1.6M | -3.09M | -3.09M | -9.02M | -9.02M | -10.6M | -7.19M | -2.42M | -6.05M | -16.74M | -4.17M | -14.86M | -19.05M | -18.9M | -12.36M | -12.75M | -10.07M |
| FCF Margin % | -123.04% | -123.04% | -58.34% | -58.34% | -240.51% | -240.51% | -1590.22% | -1590.22% | -589.98% | -199.67% | -18.93% | -34.47% | -91.27% | -31.81% | -67.34% | -88.14% | -87.9% | -60.05% | -59.43% | -48.09% |
| FCF Growth % | 18.87% | 18.87% | 82.31% | 82.31% | 70.81% | 56.96% | -272.55% | -49.17% | 36.72% | -72.41% | 83.7% | 68.23% | 11.41% | 66.26% | -16.53% | -89.1% | 72.02% | -2.54% | 8.49% | -13.23% |
| FCF per Share | -1.39 | -1.39 | -0.62 | -0.62 | -1.32 | -1.32 | -11.56 | -16.46 | -33.60 | -36.89 | -13.00 | -47.39 | -147.32 | -39.56 | -148.85 | -203.53 | -202.45 | -143.80 | -166.08 | -135.05 |
| FCF Conversion (FCF/Net Income) | 1.21x | 1.21x | 0.61x | 0.61x | 2.00x | 2.00x | 0.67x | 0.67x | -13.91x | -0.14x | 0.65x | 0.17x | 1.42x | 0.20x | 0.61x | 0.89x | 0.65x | 0.54x | 0.52x | 0.49x |
| Interest Paid | 5K | 5K | 13.5K | 13.5K | 14K | 14K | 26K | 26K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |